Malia B McAvoy1, Justin M Cappuzzo2, Christopher J Stapleton3, Matthew J Koch3, Scott B Raymond4, Collin M Torok5, Aman B Patel3. 1. Harvard-MIT Health Sciences and Technology, Harvard Medical School, Massachusetts Institute of Technology, Boston, MA, USA. 2. Department of Neurosurgery, University at Buffalo, Buffalo, NY, USA. 3. Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA. 4. Department of Radiology, Massachusetts General Hospital, Boston, MA, USA. 5. St. Paul Radiology, St. Paul, MN, USA.
Abstract
BACKGROUND: The Penumbra SMART coil is a novel device that becomes progressively softer from its distal to proximal end to maximize coil packing and prevent microcatheter prolapse or coil migration. Here, we report a large series of patients detailing the long-term experience of a single institution using the SMART coil among patients with intracranial aneurysms (IAs). METHODS: Prospective data of 105 consecutive patients with 106 IAs treated using SMART coils was collected between March 2015 and July 2018. Clinical and angiographic data were analyzed. RESULTS: Forty-nine patients (46.7%) presented with subarachnoid hemorrhage and 16 (14.2%) had recurrent aneurysms. Two patients had minor intraprocedural ruptures and remained neurologically stable. One patient had a thromboembolic complication with progressive neurologic decline. There was only one case microcatheter prolapse related to placement of a stent before coiling. An initial post-treatment modified Raymond-Roy Occlusion Classification (mRROC) I or II closure was achieved in 56 (52.8%) aneurysms. The average time to last follow-up was 8.4 months at which 70 (81.4%) aneurysms had mRROC I or II occlusion and a major recurrence was seen in 5 (5.8%) patients. Thirteen (12.3%) aneurysms required re-treatment of which one aneurysm was clipped. CONCLUSIONS: The Penumbra SMART coil is safe and effective for the endovascular treatment of appropriately selected IAs. Additional studies at multiple centers comparing safety and efficacy profile over long-term periods to other mainstream coils are necessary.
BACKGROUND: The Penumbra SMART coil is a novel device that becomes progressively softer from its distal to proximal end to maximize coil packing and prevent microcatheter prolapse or coil migration. Here, we report a large series of patients detailing the long-term experience of a single institution using the SMART coil among patients with intracranial aneurysms (IAs). METHODS: Prospective data of 105 consecutive patients with 106 IAs treated using SMART coils was collected between March 2015 and July 2018. Clinical and angiographic data were analyzed. RESULTS: Forty-nine patients (46.7%) presented with subarachnoid hemorrhage and 16 (14.2%) had recurrent aneurysms. Two patients had minor intraprocedural ruptures and remained neurologically stable. One patient had a thromboembolic complication with progressive neurologic decline. There was only one case microcatheter prolapse related to placement of a stent before coiling. An initial post-treatment modified Raymond-Roy Occlusion Classification (mRROC) I or II closure was achieved in 56 (52.8%) aneurysms. The average time to last follow-up was 8.4 months at which 70 (81.4%) aneurysms had mRROC I or II occlusion and a major recurrence was seen in 5 (5.8%) patients. Thirteen (12.3%) aneurysms required re-treatment of which one aneurysm was clipped. CONCLUSIONS: The Penumbra SMART coil is safe and effective for the endovascular treatment of appropriately selected IAs. Additional studies at multiple centers comparing safety and efficacy profile over long-term periods to other mainstream coils are necessary.
Authors: Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman Journal: Lancet Date: 2002-10-26 Impact factor: 79.321
Authors: Christopher J Stapleton; Collin M Torok; James D Rabinov; Brian P Walcott; Justin R Mascitelli; Thabele M Leslie-Mazwi; Joshua A Hirsch; Albert J Yoo; Christopher S Ogilvy; Aman B Patel Journal: J Neurointerv Surg Date: 2015-10-05 Impact factor: 5.836
Authors: Alejandro M Spiotta; Kyle M Fargen; Jonathan Lena; Imran Chaudry; Raymond D Turner; Aquilla S Turk; Daniel Huddle; David Loy; Richard Bellon; Donald Frei Journal: World Neurosurg Date: 2016-09-15 Impact factor: 2.104
Authors: Justin R Mascitelli; Eric K Oermann; Reade A De Leacy; Henry Moyle; Aman B Patel Journal: J Neurointerv Surg Date: 2014-05-02 Impact factor: 5.836
Authors: Bernard R Bendok; Karl R Abi-Aad; Jennifer D Ward; Jason F Kniss; Mary J Kwasny; Rudy J Rahme; Salah G Aoun; Tarek Y El Ahmadieh; Najib E El Tecle; Samer G Zammar; Rami James N Aoun; Devi P Patra; Sameer A Ansari; Jean Raymond; Henry H Woo; David Fiorella; Guilherme Dabus; Genevieve Milot; Josser E Delgado Almandoz; John A Scott; Andrew J DeNardo; Shervin R Dashti Journal: Neurosurgery Date: 2020-05-01 Impact factor: 4.654